136 related articles for article (PubMed ID: 27866658)
1. Effect of Modulated Electrohyperthermia on the Pharmacokinetics of Oral Transmucosal Fentanyl Citrate in Healthy Volunteers.
Lee SY; Kim MG
Clin Ther; 2016 Dec; 38(12):2548-2554. PubMed ID: 27866658
[TBL] [Abstract][Full Text] [Related]
2. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
Parikh N; Goskonda V; Chavan A; Dillaha L
Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761
[TBL] [Abstract][Full Text] [Related]
3. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
4. Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers.
Egan TD; Sharma A; Ashburn MA; Kievit J; Pace NL; Streisand JB
Anesthesiology; 2000 Mar; 92(3):665-73. PubMed ID: 10719944
[TBL] [Abstract][Full Text] [Related]
5. Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study.
Vasisht N; Gever LN; Tagarro I; Finn AL
Clin Drug Investig; 2009; 29(10):647-54. PubMed ID: 19715381
[TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic study to compare two simultaneous 400 microg doses with a single 800 microg dose of oral transmucosal fentanyl citrate.
Lee M; Kern SE; Kisicki JC; Egan TD
J Pain Symptom Manage; 2003 Aug; 26(2):743-7. PubMed ID: 12906959
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and relative bioavailability of fentanyl pectin nasal spray 100 - 800 µg in healthy volunteers.
Fisher A; Watling M; Smith A; Knight A
Int J Clin Pharmacol Ther; 2010 Dec; 48(12):860-7. PubMed ID: 21084042
[TBL] [Abstract][Full Text] [Related]
8. Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate.
Streisand JB; Busch MA; Egan TD; Smith BG; Gay M; Pace NL
Anesthesiology; 1998 Feb; 88(2):305-9. PubMed ID: 9477048
[TBL] [Abstract][Full Text] [Related]
9. Faster absorption and higher systemic bioavailability of intranasal fentanyl spray compared to oral transmucosal fentanyl citrate in healthy subjects.
Nave R; Schmitt H; Popper L
Drug Deliv; 2013; 20(5):216-23. PubMed ID: 23650968
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188.
Fisher A; Watling M; Smith A; Knight A
Int J Clin Pharmacol Ther; 2010 Feb; 48(2):138-45. PubMed ID: 20137766
[TBL] [Abstract][Full Text] [Related]
11. Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate.
Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
J Clin Pharmacol; 2007 Mar; 47(3):343-50. PubMed ID: 17322146
[TBL] [Abstract][Full Text] [Related]
12. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial.
Mercadante S; Radbruch L; Davies A; Poulain P; Sitte T; Perkins P; Colberg T; Camba MA
Curr Med Res Opin; 2009 Nov; 25(11):2805-15. PubMed ID: 19792837
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines.
Aronoff GM; Brennan MJ; Pritchard DD; Ginsberg B
Pain Med; 2005; 6(4):305-14. PubMed ID: 16083461
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Pharmacokinet; 2005; 44(12):1279-86. PubMed ID: 16372825
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
[TBL] [Abstract][Full Text] [Related]
16. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.
Christie JM; Simmonds M; Patt R; Coluzzi P; Busch MA; Nordbrock E; Portenoy RK
J Clin Oncol; 1998 Oct; 16(10):3238-45. PubMed ID: 9779697
[TBL] [Abstract][Full Text] [Related]
17. Influence of age on the pharmacokinetics and pharmacodynamics of oral transmucosal fentanyl citrate.
Kharasch ED; Hoffer C; Whittington D
Anesthesiology; 2004 Sep; 101(3):738-43. PubMed ID: 15329599
[TBL] [Abstract][Full Text] [Related]
18. Dose Proportionality and Pharmacokinetics of Fentanyl Buccal Soluble Film in Healthy Subjects : A Phase I, Open-Label, Three-Period, Crossover Study.
Finn AL; Vasisht N; Stark JG; Gever LN; Tagarro I
Clin Drug Investig; 2012 Jan; 32(1):63-71. PubMed ID: 27933600
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of the intravenous formulation of fentanyl citrate administered orally in children undergoing general anesthesia.
Wheeler M; Birmingham PK; Lugo RA; Heffner CL; Coté CJ
Anesth Analg; 2004 Nov; 99(5):1347-1351. PubMed ID: 15502029
[TBL] [Abstract][Full Text] [Related]
20. Effect of dosing interval on pharmacokinetics of fentanyl pectin nasal spray from a crossover study.
Chen C; Bujanover S; Gupta A
J Opioid Manag; 2015; 11(2):139-46. PubMed ID: 25901479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
